The National Health Council (NHC), in partnership with the Genetic Alliance (GA) and Food and Drug Law Institute (FDLI), is hosting a conference on good practices for sponsor-patient interactions as part of achieving meaningful patient engagement in drug development with a goal of establishing recommendations to inform company and patient advocacy group policy.
The conference, Sponsor-Patient Interactions: Establishing Consensus on Good Practices for Patient Engagement in Drug Development, will be held on Thursday, June 15 in Washington, DC, at the Capital Hilton (1001 16th Street NW, Washington, DC 20036. Federal AB room) from 10:00 a.m. to 4:00 p.m.
· NHC Members*: No fee
· Non-Members: $299
* The NHC welcomes all stakeholders to attend this meeting. Non-NHC members can register for a fee of $299 per attendee. NHC Members from Business & Industry can register one attendee at no charge. Each additional attendee from Business & Industry members can register for $299 per attendee. NHC Members from Voluntary Health Agencies or Nonprofit Organizations may send additional attendees at no additional fee.
Payment Info: Click here for the conference payment form. Email the completed form to Rachel Stivers. You will receive a confirmation email once your payment has been processed. If you prefer to call the NHC with your payment information, please call Rachel at 202-973-0547.
AGENDA COMING SOON
This is a topic of interest to many across the health care community and we hope you will be able to join us. If you have any questions, please email Rachel Stivers, NHC Public Policy Associate.
If you are interested in learning more about sponsorship opportunities, please contact Kelly Garrity, NHC Senior Director, Member Services and Development.